Cytokines in cancer pathogenesis and cancer therapy

被引：1137

作者：

Dranoff, G ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[2] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA

[3] Harvard Univ, Sch Med, Boston, MA 02115 USA

来源：

NATURE REVIEWS CANCER | 2004年 / 4卷 / 01期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1038/nrc1252

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The mixture of cytokines that is produced in the tumour microenvironment has an important role in cancer pathogenesis. Cytokines that are released in response to infection, inflammation and immunity can function to inhibit tumour development and progression. Alternatively, cancer cells can respond to host-derived cytokines that promote growth, attenuate apoptosis and facilitate invasion and metastasis. A more detailed understanding of cytokine-tumour-cell interactions provides new opportunities for improving cancer immunotherapy.

引用

页码：11 / 22

页数：12

共 138 条

[21] Immune enhancement of skin carcinogenesis by CD4+T cells
Daniel, D
Meyer-Morse, N
Bergsland, EK
Dehne, K
Coussens, LM
Hanahan, D
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (08) : 1017 - 1028
[22] Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions
Davidson, WF
Giese, T
Fredrickson, TN
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (11) : 1825 - 1838
[23] Delannoy A, 1997, J NATL CANCER I, V89, P1616
[24] Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study
Demetri, GD
Kris, M
Wade, J
Degos, L
Cella, D
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) : 3412 - 3425
[25] The innate immune response to tumors and its role in the induction of T-cell immunity
Diefenbach, A
Raulet, DH
[J]. IMMUNOLOGICAL REVIEWS, 2002, 188 : 9 - 21
[26] Induction of cytotoxic T lymphocyte antigen 4 (CTLA-4) restricts clonal expansion of helper T cells
Doyle, AM
Mullen, AC
Villarino, AV
Hutchins, AS
High, FA
Lee, HW
Thompson, CB
Reiner, SL
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (07) : 893 - 902
[27] GENE-TRANSFER AS CANCER-THERAPY
DRANOFF, G
MULLIGAN, RC
[J]. ADVANCES IN IMMUNOLOGY, VOL 58, 1995, 58 : 417 - 454
[28] VACCINATION WITH IRRADIATED TUMOR-CELLS ENGINEERED TO SECRETE MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR STIMULATES POTENT, SPECIFIC, AND LONG-LASTING ANTITUMOR IMMUNITY
DRANOFF, G
JAFFEE, E
LAZENBY, A
GOLUMBEK, P
LEVITSKY, H
BROSE, K
JACKSON, V
HAMADA, H
PARDOLL, D
MULLIGAN, RC
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) : 3539 - 3543
[29] 2 UPSTREAM ELEMENTS ACTIVATE TRANSCRIPTION OF A MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I GENE INVITRO
DRIGGERS, PH
ELENBAAS, BA
AN, JB
LEE, IJ
OZATO, K
[J]. NUCLEIC ACIDS RESEARCH, 1992, 20 (10) : 2533 - 2540
[30] Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, GP
Bruce, AT
Ikeda, H
Old, LJ
Schreiber, RD
[J]. NATURE IMMUNOLOGY, 2002, 3 (11) : 991 - 998

← 1 2 3 4 5 6 7 8 9 10 →